151 related articles for article (PubMed ID: 6445072)
1. The effect of radiopharmaceutical incubation time on bone scan quality.
Henkin RE; Woodruff A; Chang W; Green AM
Radiology; 1980 May; 135(2):463-6. PubMed ID: 6445072
[TBL] [Abstract][Full Text] [Related]
2. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
Tan KF; Chang CH
Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
[No Abstract] [Full Text] [Related]
3. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. Gastric visualization and image quality in radionuclide bone scanning: concise communication.
Wilson MA; Pollack MJ
J Nucl Med; 1981 Jun; 22(6):518-21. PubMed ID: 6453210
[TBL] [Abstract][Full Text] [Related]
6. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
Isobe Y; Ko S; Umegaki Y; Takahashi S; Kawaguchi N; Wada S; Matsumoto S
Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
[No Abstract] [Full Text] [Related]
7. [An evaluation of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) as a new bone scanning agent (author's transl)].
Hayashi M; Takahashi K; Furukawa K; Hazue M; Shibatsuji H; Yasuda N; Tanaka K; Yoshikawa I; Maeda K; Hamada S
Radioisotopes; 1981 Jan; 30(1):38-9. PubMed ID: 7268059
[No Abstract] [Full Text] [Related]
8. [Relationship between soft tissue calcification and calcium--phosphorus product in uremic patients studied by 99mTc-methylene diphosphonate bone scan].
Shieh SD; Chen WL; Huang HW; Fan CD
Taiwan Yi Xue Hui Za Zhi; 1983 Jan; 82(1):91-8. PubMed ID: 6223115
[No Abstract] [Full Text] [Related]
9. [Value and limitations of scintigraphy based on methylene diphosphonate pyrophosphate labeled with 99m technetium in the monitoring of revascularized bone transplants].
Clouet M; Chavoin JP; Vigoni F; Pessey JJ; Costagliola M
Ann Chir Plast; 1981; 26(3):217-20. PubMed ID: 6458230
[No Abstract] [Full Text] [Related]
10. [Bone scintigraphy with 99mTc-hydroxy methylene diphosphonate (99mTc-HMDP) (author's transl)].
Okahashi S; Ishimaru T; Maeda H; Sakata T; Yamasaki K; Akagi H
Radioisotopes; 1981 Aug; 30(8):458-60. PubMed ID: 7335921
[No Abstract] [Full Text] [Related]
11. Labeling efficiency and stomach concentration in methylene diphosphonate bone imaging.
Dhawan V; Yeh SD
J Nucl Med; 1979 Jul; 20(7):791-3. PubMed ID: 541718
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
13. [An experimental crossover study between hydroxymethylene diphosphonate kit and methylene diphosphonate (author's transl)].
Nagai K; Muranaka A; Otsuka N; Terashima H; Yanagimoto S; Nagase N; Ito Y
Radioisotopes; 1982 Jan; 31(1):32-4. PubMed ID: 6461888
[No Abstract] [Full Text] [Related]
14. [Bone scintigraphy with 99mTc-labeled methylene diphosphonate in hemodialysis patients (author's transl)].
Yamashita M; Aoki T; Kakiuchi T; Mabuchi H; Tabata Y; Murao Y; Nishizawa H; Maruyama Y; Kishi Y; Nakahashi H; Murakami K
Radioisotopes; 1981 Nov; 30(11):609-11. PubMed ID: 6461029
[No Abstract] [Full Text] [Related]
15. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
Buell U; Kirsch CM; Kleinhans E; Jäger B
J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
[No Abstract] [Full Text] [Related]
17. [99mTc methylene diphosphonate bone scans in primary hyperparathyroidism].
Shimizu E; Moriyama M; Okamoto Y; Ota K; Maeda J; Torizumi K
Radioisotopes; 1985 May; 34(5):278-81. PubMed ID: 2930869
[No Abstract] [Full Text] [Related]
18. Studies in skeletal tracer kinetics. V: Computer-simulated Tc-99m (Sn)MDP bone-scan changes in some systemic disorders: concise communication.
Charkes ND; Makler PT
J Nucl Med; 1981 Jul; 22(7):601-5. PubMed ID: 6454764
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
MacDonald J
J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m methylene diphosphonate (MDP) bone imaging: optimum normal bone scan by optimum time delay?
Buell U
J Nucl Med; 1981 Jan; 22(1):95-6. PubMed ID: 7452362
[No Abstract] [Full Text] [Related]
[Next] [New Search]
